Cargando…

Cost-benefit of COVID-19 lockdown in the UK

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441139/ https://www.ncbi.nlm.nih.gov/pubmed/32843836 http://dx.doi.org/10.1007/s40274-020-7058-0

Ejemplares similares

National lockdown not cost effective in Israel during COVID-2 pandemic
Publicado: (2021)

Notes on cost benefit of COVID‐19 lockdown
por: Mills, Michael, et al.
Publicado: (2020)

A cost–benefit analysis of COVID-19 lockdowns in Australia
por: Lally, Martin
Publicado: (2022)

Benefit-risk assessment for remdesivir in COVID-19
Publicado: (2020)

Are We Better-Off? The Benefits and Costs of Australian COVID-19 Lockdown
por: Pak, Anton, et al.
Publicado: (2021)

The total hospital and community UK costs of managing patients with relapsed breast cancer
por: Thomas, R J, et al.
Publicado: (2009)

Risk-benefit of AstraZeneca COVID-19 vaccination in Australia
Publicado: (2021)

Costs of active COVID-19 testing in Canada
Publicado: (2020)

Counting the cost of COVID-19 at the peak of the pandemic in Spain
Publicado: (2021)

Testing and restrictions are cost-effective COVID-19 measures
Publicado: (2021)

Remdesivir cost effective for severe COVID-19 in China
Publicado: (2021)

COVID-19 vaccination predicted to be cost effective in USA
Publicado: (2021)

Estimated direct costs of COVID-19 pandemic high in Turkey, but true costs "undoubtedly higher"
Publicado: (2021)

Maternal mental health and coping during the COVID‐19 lockdown in the UK: Data from the COVID‐19 New Mum Study
por: Dib, Sarah, et al.
Publicado: (2020)

Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India
por: Freedberg, Kenneth A., et al.
Publicado: (2018)

Expanded testing for COVID-19 could be cost effective in USA
Publicado: (2020)

COVID-19 control strategies cost effective in South Africa
Publicado: (2020)

Cost effective COVID-19 mitigation measures in US colleges
Publicado: (2021)

Rapid COVID-19 movement restrictions reduce societal costs
Publicado: (2021)

Productivity losses impact cost effectiveness of COVID-19 vaccine
Publicado: (2021)

Costs of ICU care during COVID-19 pandemic in USA
Publicado: (2021)

Tocilizumab cost effective in reducing COVID-19-related deaths
Publicado: (2021)

COVID-19 and ‘lockdown’ in organ transplantation in the UK
por: Gumber, L., et al.
Publicado: (2020)

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Menon, Usha, et al.
Publicado: (2017)

Best COVID-19 vaccine allocation strategy using a net-monetary benefit approach?
Publicado: (2021)

Substantial direct medical costs for symptomatic COVID-19 cases in the US
Publicado: (2020)

Easing of COVID-19 social restrictions in England comes at a cost
Publicado: (2021)

Effects on LOS may not justify cost of remdesivir for severe COVID-19
Publicado: (2021)

ICU bed reserve capacity for COVID-19 cost effective in Germany
Publicado: (2021)

COVID-19 pandemic associated with substantial costs in older Medicare beneficiaries
Publicado: (2021)

Expediting COVID-19 vaccination increases QALYs and saves costs in the USA
Publicado: (2021)

The impact of the first COVID-19 lockdown on weight management practices in UK adults: A self-regulation perspective
por: Genes, Denisa, et al.
Publicado: (2023)

Universal COVID-19 vaccination cost saving unless anaphylaxis rate high
Publicado: (2021)

Health care costs for the treatment of breast cancer recurrent events: estimates from a UK-based patient-level analysis
por: Karnon, J, et al.
Publicado: (2007)

The passage of time during the UK Covid-19 lockdown
por: Ogden, Ruth S.
Publicado: (2020)

COVID-19 UK Lockdown Forecasts and R(0)
por: Dropkin, Greg
Publicado: (2020)

The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India
por: Babu, Govind, et al.
Publicado: (2016)

Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2 years (2009–2010)
por: Liniker, E, et al.
Publicado: (2013)

Baricitinib + SOC cost effective vs SOC for patients hospitalised with COVID-19 in the USA
Publicado: (2021)

Remdesivir may be cost saving in eligible patients during COVID-19 infections in Germany
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kpg7hgsc0ik63stku82gblep1p